中泰證券(600918.SH)上半年淨利預增20%-30%
格隆匯7月21日丨中泰證券(600918.SH)披露2021年半年度業績預增公吿,預計2021年上半年實現歸屬於上市公司股東的淨利潤與上年同期相比,將增加2.77億元-4.15億元,同比增長20%-30%;歸屬於上市公司股東的扣除非經常性損益的淨利潤與上年同期相比,將增加2.59億元-3.95億元,同比增長19%-29%。
業績預增的主要原因系:2021年上半年,公司按照“一個統領、一箇中心、四大戰略、兩個支撐”的發展思路,堅持以客户為中心,深入推進區域突破戰略,全面提升綜合金融服務能力,持續加強風險管理,積極把握市場機遇,投行業務、投資業務、經紀業務等業務收入實現了穩步增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.